Our Insights
China's Innovation Drug Policy: Five Impacts on Taiwan Biotech
China's Innovation Drug Policy: Five Impacts on Taiwan BiotechChina's Several Measures to Support High-Quality Development of Innovative Drugs represents a strategic overhaul of its pharmaceutical ecosystem. Covering R&D through reimbursement via 16...
China's Innovation Drug Policy: Five Impacts on Taiwan Biotech
China's Innovation Drug Policy: Five Impacts on Taiwan BiotechChina's Several Measures to Support High-Quality Development of Innovative Drugs represents a strategic overhaul of its pharmaceutical ecosystem. Covering R&D through reimbursement via 16...
AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.
AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.The global biotech market continues its growth trajectory, projected to rise from US$483 billion in 2024...
AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.
AI and Tariffs Under Siege: How Can Taiwan's Biotech Industry Break the Impasse? (1)-Corporate culture.The global biotech market continues its growth trajectory, projected to rise from US$483 billion in 2024...
Global Market Access Strategy for Innovative Wound Care Products
Global wound care market entry demands regulatory compliance, strong clinical data, strategic partnerships, and tailored commercialization to overcome challenges and achieve sustainable growth.
Global Market Access Strategy for Innovative Wound Care Products
Global wound care market entry demands regulatory compliance, strong clinical data, strategic partnerships, and tailored commercialization to overcome challenges and achieve sustainable growth.
Accelerating Commercialization of Innovative Wound Care Technologies: A Biotech Roadmap
Biotech firms must strategically navigate regulations, partnerships, and clinical validation to rapidly commercialize advanced wound care technologies, improving patient outcomes through innovation.
Accelerating Commercialization of Innovative Wound Care Technologies: A Biotech Roadmap
Biotech firms must strategically navigate regulations, partnerships, and clinical validation to rapidly commercialize advanced wound care technologies, improving patient outcomes through innovation.
"A bustling Chinese pharmacy with shelves overflowing with colorful medications, a pharmacist in a white coat consulting with a patient, and a modern pharmaceutical factory in the background."
China is biggest market in Asia, no one can ignore it, thus, IUSEA also support to enter China market, IUSEA China Consultancy to share below policy for reference. Opportunities for...
"A bustling Chinese pharmacy with shelves overflowing with colorful medications, a pharmacist in a white coat consulting with a patient, and a modern pharmaceutical factory in the background."
China is biggest market in Asia, no one can ignore it, thus, IUSEA also support to enter China market, IUSEA China Consultancy to share below policy for reference. Opportunities for...
Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.
Regenerative medicine including Stem cell and Exosome related products are developed by Biotech Co.. in Taiwan in recent years; But, due to regulation limited, only cosmetic products were approved for...
Exosomes contribute to anti-aging, including cellular communication, tissue repair, inflammation reduction, and oxidative stress mitigation.
Regenerative medicine including Stem cell and Exosome related products are developed by Biotech Co.. in Taiwan in recent years; But, due to regulation limited, only cosmetic products were approved for...
